HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.
2nd Edition of Cardiology World Conference
September 17-18, 2021 | Paris, France
Campanile Roissy-en-France Hotel
Roissy Park Activity Area - Allee Des Vergers 95700 Roissy in France
Paris, France
Roissy Park Activity Area - Allee Des Vergers 95700 Roissy in France
Paris, France
Phone : 1 (702) 988 2320
Toll Free: 1800–883-8082
Whatsapp: +1 434 381 1007
Email: [email protected]
Toll Free: 1800–883-8082
Whatsapp: +1 434 381 1007
Email: [email protected]
Cardiovascular Pharmacology
Cardiovascular Pharmacology
Cardiovascular pharmacology: Cardiovascular pharmacology involves drugs that are used in the treatment of cardiovascular diseases. Many medications are used to treat various heart conditions. Some examples of the drugs used as cardiovascular medicine include:
- Anticoagulants or blood thinners
- Antiplatelet agents
- Thrombolytic agents
- Angiotensin-converting enzyme (ACE) inhibitors
- Angiotensin II receptor blockers (ARBs)
- Diuretics
- Calcium channel blockers
- Vasodilators
- Digoxin
Committee Members
John Horowitz
University of Adelaide, Australia
James Ratcliff
Rowpar Pharmaceuticals, USA
Mikhail Rudenko
Russian New University, Russia 2021 Speakers
Keith A. Horvath
Formerly Director of Cardiothoracic Surgical Research Program NIH, United States
Abdelhamid Errachid
Head of the Micro & Nanobiotechnology Group, France
Aaron Monga
Western University of the Health Sciences, United States of America
Iryna Melnychuk
National medical university, UkraineSubmit your abstract Today
Title : Inflammation and oral pathogens as determinants of Hypertension
James Ratcliff, Rowpar Pharmaceuticals, USA
Title : Coronary artery spasm: Pathogenesis, diagnosis and treatment
John Horowitz, University of Adelaide, Australia
Title : Acute coronary syndrome Complecated with acuteaortic aissection Type A
Christos S. Simoglou, Department of Cardiothoracic Surgery Private Clinic, Greece
Title : Integrative metabolic therapeutic approach for symptomatic patients with left ventricular dilatation and reduced ejection fraction
Mila Jakovljevic, Polyclinic for Cardiovascular Diseases and Prevention, Croatia
Title : The effect of COVID-19 infection on cardiac function in patients with pre-existing heart failure.
Hasan Jamjoom, London North West Hospital trust, United Kingdom
Title : To be Announced.......
Keith A. Horvath, NHLBI, United States
Title : Right ventricular outflow tract sparing versus annulus-sparing with Right ventricular
Jinyang liu, Fuwai Hospital, China
Title : Implementation of the fundamental theory of cardiometry in diagnostic and therapeutic devices
Mikhail Rudenko, Russian New University, Russian Federation
Title : Variation in Clinical Manifestations of Left Atrial Myxoma Patients: Serial case report
Michi Sitepu, University of Padjajaran, Indonesia
Title : Trimethylamine and Trimethylamine-n-oxide levels in Coronary heart disease patients with atrial fibrillation paroxysm
Iryna Melnychuk, O.O. Bogomolets National Medical University, Ukraine